Selected research
Market Structure
Global Huntington's Disease Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Huntington's Disease Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Huntington's Disease Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Huntington's Disease Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Huntington's Disease Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Huntington's Disease Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Huntington's Disease Therapeutics include Teva Pharmaceutical Industries, Prana Biotechnology, Horizon Pharma, H. Lundbeck and F. Hoffmann-La Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Huntington's Disease Therapeutics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Huntington's Disease Therapeutics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Huntington's Disease Therapeutics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Huntington's Disease Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.
Huntington's Disease Therapeutics Segment by Company
Teva Pharmaceutical Industries
Prana Biotechnology
Horizon Pharma
H. Lundbeck
F. Hoffmann-La Roche
Huntington's Disease Therapeutics Segment by Type
Antidepressants
Anticonvulsants
Antipsychotics
Antidopaminergics
Huntington's Disease Therapeutics Segment by Application
Clinics
Diagnostic Centers
Hospitals
Huntington's Disease Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Huntington's Disease Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Huntington's Disease Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Huntington's Disease Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Huntington's Disease Therapeutics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Huntington's Disease Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Huntington's Disease Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Huntington's Disease Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Antidepressants
- Anticonvulsants
- Antipsychotics
- Antidopaminergics
Applications
- Clinics
- Diagnostic Centers
- Hospitals
Companies covered
- Teva Pharmaceutical Industries
- Prana Biotechnology
- Horizon Pharma
- H. Lundbeck
- F. Hoffmann-La Roche
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Huntington's Disease Therapeutics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Huntington's Disease Therapeutics Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Huntington's Disease Therapeutics Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Huntington's Disease Therapeutics Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Huntington's Disease Therapeutics Market Dynamics
- 2.1 Huntington's Disease Therapeutics Industry Trends
- 2.2 Huntington's Disease Therapeutics Industry Drivers
- 2.3 Huntington's Disease Therapeutics Industry Opportunities and Challenges
- 2.4 Huntington's Disease Therapeutics Industry Restraints
3 Huntington's Disease Therapeutics Market by Manufacturers
- 3.1 Global Huntington's Disease Therapeutics Revenue by Manufacturers (2021-2026)
- 3.2 Global Huntington's Disease Therapeutics Sales by Manufacturers (2021-2026)
- 3.3 Global Huntington's Disease Therapeutics Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Huntington's Disease Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Huntington's Disease Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Huntington's Disease Therapeutics Manufacturers, Product Type & Application
- 3.7 Global Huntington's Disease Therapeutics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Huntington's Disease Therapeutics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Huntington's Disease Therapeutics Players Market Share by Revenue in 2025
- 3.8.3 2025 Huntington's Disease Therapeutics Tier 1, Tier 2, and Tier 3
4 Huntington's Disease Therapeutics Market by Type
- 4.1 Huntington's Disease Therapeutics Type Introduction
- 4.1.1 Antidepressants
- 4.1.2 Anticonvulsants
- 4.1.3 Antipsychotics
- 4.1.4 Antidopaminergics
- 4.2 Global Huntington's Disease Therapeutics Sales by Type
- 4.2.1 Global Huntington's Disease Therapeutics Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Huntington's Disease Therapeutics Sales by Type (2021-2032)
- 4.2.3 Global Huntington's Disease Therapeutics Sales Market Share by Type (2021-2032)
- 4.3 Global Huntington's Disease Therapeutics Revenue by Type
- 4.3.1 Global Huntington's Disease Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Huntington's Disease Therapeutics Revenue by Type (2021-2032)
- 4.3.3 Global Huntington's Disease Therapeutics Revenue Market Share by Type (2021-2032)
5 Huntington's Disease Therapeutics Market by Application
- 5.1 Huntington's Disease Therapeutics Application Introduction
- 5.1.1 Clinics
- 5.1.2 Diagnostic Centers
- 5.1.3 Hospitals
- 5.2 Global Huntington's Disease Therapeutics Sales by Application
- 5.2.1 Global Huntington's Disease Therapeutics Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Huntington's Disease Therapeutics Sales by Application (2021-2032)
- 5.2.3 Global Huntington's Disease Therapeutics Sales Market Share by Application (2021-2032)
- 5.3 Global Huntington's Disease Therapeutics Revenue by Application
- 5.3.1 Global Huntington's Disease Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Huntington's Disease Therapeutics Revenue by Application (2021-2032)
- 5.3.3 Global Huntington's Disease Therapeutics Revenue Market Share by Application (2021-2032)
6 Global Huntington's Disease Therapeutics Sales by Region
- 6.1 Global Huntington's Disease Therapeutics Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Huntington's Disease Therapeutics Sales by Region (2021-2032)
- 6.2.1 Global Huntington's Disease Therapeutics Sales by Region (2021-2026)
- 6.2.2 Global Huntington's Disease Therapeutics Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Huntington's Disease Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Huntington's Disease Therapeutics Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Huntington's Disease Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Huntington's Disease Therapeutics Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Huntington's Disease Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Huntington's Disease Therapeutics Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Huntington's Disease Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Huntington's Disease Therapeutics Revenue by Region
- 7.1 Global Huntington's Disease Therapeutics Revenue by Region
- 7.1.1 Global Huntington's Disease Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Huntington's Disease Therapeutics Revenue by Region (2021-2026)
- 7.1.3 Global Huntington's Disease Therapeutics Revenue by Region (2027-2032)
- 7.1.4 Global Huntington's Disease Therapeutics Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Huntington's Disease Therapeutics Revenue (2021-2032)
- 7.2.2 North America Huntington's Disease Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Huntington's Disease Therapeutics Revenue (2021-2032)
- 7.3.2 Europe Huntington's Disease Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Huntington's Disease Therapeutics Revenue (2021-2032)
- 7.4.2 Asia-Pacific Huntington's Disease Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Huntington's Disease Therapeutics Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Huntington's Disease Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva Pharmaceutical Industries
- 8.1.1 Teva Pharmaceutical Industries Company Information
- 8.1.2 Teva Pharmaceutical Industries Business Overview
- 8.1.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product Portfolio
- 8.1.5 Teva Pharmaceutical Industries Recent Developments
- 8.2 Prana Biotechnology
- 8.2.1 Prana Biotechnology Company Information
- 8.2.2 Prana Biotechnology Business Overview
- 8.2.3 Prana Biotechnology Huntington's Disease Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Prana Biotechnology Huntington's Disease Therapeutics Product Portfolio
- 8.2.5 Prana Biotechnology Recent Developments
- 8.3 Horizon Pharma
- 8.3.1 Horizon Pharma Company Information
- 8.3.2 Horizon Pharma Business Overview
- 8.3.3 Horizon Pharma Huntington's Disease Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Horizon Pharma Huntington's Disease Therapeutics Product Portfolio
- 8.3.5 Horizon Pharma Recent Developments
- 8.4 H. Lundbeck
- 8.4.1 H. Lundbeck Company Information
- 8.4.2 H. Lundbeck Business Overview
- 8.4.3 H. Lundbeck Huntington's Disease Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 H. Lundbeck Huntington's Disease Therapeutics Product Portfolio
- 8.4.5 H. Lundbeck Recent Developments
- 8.5 F. Hoffmann-La Roche
- 8.5.1 F. Hoffmann-La Roche Company Information
- 8.5.2 F. Hoffmann-La Roche Business Overview
- 8.5.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Product Portfolio
- 8.5.5 F. Hoffmann-La Roche Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Huntington's Disease Therapeutics Value Chain Analysis
- 9.1.1 Huntington's Disease Therapeutics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Huntington's Disease Therapeutics Production Mode & Process
- 9.2 Huntington's Disease Therapeutics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Huntington's Disease Therapeutics Distributors
- 9.2.3 Huntington's Disease Therapeutics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst